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The purpose of this study is to assess the effects of propacetamol on attenuating hemodynamic responses subsequent laryngoscopy
and tracheal intubation compared to lidocaine. In this randomized clinical trial, 62 patients with the American Anesthesiologists
Society (ASA) class I/II who required laryngoscopy and tracheal intubation for elective surgery were assigned to receive propaceta-
mol 2 g/I.V./infusion (group P) or lidocaine 1.5mg/kg (group L) prior to laryngoscopy. Systolic and diastolic blood pressures (SBP,
DBP), mean arterial pressure (MAP), and heart rate (HR) were recorded at baseline, before laryngoscopy and within nine minutes
after intubation. In both groups P andL,MAP increased after laryngoscopy and the changeswere statistically significant (𝑃 < 0.001).
There were significant changes of HR in both groups after intubation (𝑃 < 0.02), but the trend of changes was different between
two groups (𝑃 < 0.001). In group L, HR increased after intubation and its change was statistically significant within 9 minutes after
intubation (𝑃 < 0.001), while in groupP,HR remained stable after intubation (𝑃 = 0.8). Propacetamol 2 gr one hour prior intubation
attenuates heart rate responses after laryngoscopy but is not effective to prevent acute alterations in blood pressure after intubation.
1. Introduction
Propacetamol [4-(acetamido)phenylN,N-diethylglycinate] is
a prodrug, which is quickly hydrolyzed by plasma esterase
to vigorous paracetamol; 1 gr propacetamol metabolized to
500mg paracetamol [1]. It has an onset of about half an hour
to an hour, has a half-life of one to four hours, and has
duration effect of six to eight hours. Its optimal effects appear
about one hour after injection and its maximum recom-
mended dose in adults is 4 grams per day. This drug inhibits
prostaglandins synthesis in the central nervous system and
also blocks pain impulses peripherally and has antipyretic
effects through hypothalamus [2]. This drug is safe, cost
effective and its beneficial effects for pain management and
reducing opioids amounts have been confirmed in patients
who underwent dental, orthopaedic and gynaecologic surg-
eries [3–8].
Laryngoscopy and tracheal intubation are among the
most painful processes carried out on the human body which
are associated with acute hemodynamic responses, lasting for
at least ten minutes [3–9]. Sympathoadrenal stimulation and
subsequent catecholamine release may partially contribute to
this hemodynamic instability, which is typically signified by
an increase in heart rate (HR) and blood pressure (BP) [10];
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however, the main mechanism is not clearly defined. These
acute changes in hemodynamic status are particularly sig-
nificant in patients with preexisting predisposing situations
like hypertension, myocardial infarction, myocardial mal-
function, and cardiovascular diseases [11, 12].
Various techniques have been examined for attenuat-
ing hemodynamic responses to laryngoscopy and tracheal
intubation, including deeper anaesthesia [10], and numerous
drugs, such as beta blockers [13, 14], calcium channel block-
ers [15], opioids [16–18], sodium channel blockers [18, 19],
vasodilators [20], and alpha agonists [21]. Opioids are the
most commonly used drugs with satisfactory outcomes for
preventing hemodynamic subsequence of intubation. These
drugs are not cost effective, however, and are associated with
some unfavourable complications such as nausea, vomiting,
consumedly sedation, and respiratory depression [22].There-
fore, there has been a growing trend to find an effective
substitute to reduce these side effects as much as possible
[23, 24]. However, the beneficial effects of propacetamol
have been confirmed for postoperative pain management.
The purpose of this study is to assess the effects of propac-
etamol on attenuating hemodynamic responses subsequent
laryngoscopy and tracheal intubation compared to lidocaine,
which is routinely used in most of operation rooms.
2. Subjects and Methods
2.1. Study Design, Inclusion and Exclusion Criteria. This
single-blind randomized clinical trial was conducted between
January 2010 and September 2011. The study protocol was
approved by the ethical committee of Tehran University of
Medical Sciences (TUMS).The cases were selected among the
patients who underwent elective gynecologic and reconstruc-
tive surgeries in two operating rooms of Imam Khomeini
Hospital, in Tehran, Iran. These cases had laryngoscopy
and tracheal intubation before the surgery. The inclusion
criteria were patients between the ages of 20 and 60 as
well as American Anesthesiologists society (ASA) classes
I and II. Patients with preexisting conditions were not
included, namely, hard intubation (previous history of hard
intubation, laryngoscopic view >II, body mass index >30,
micrognathia, andmacroglossia), diabetic patients with auto-
nomic dysfunction, patients with renal and liver dysfunction,
patients with a history of cardiovascular disease, hyper-
tension, cerebrovascular diseases, respiratory disease (e.g.,
asthma), pheochromocytoma, cushing’s syndrome, opium
addiction, propacetamol or lidocaine contraindications, and
hypersensitivity, and patients who needed emergent surgery.
2.2. Randomization and Study Protocol. The study protocol
was explained in detail for those who met the inclusion
criteria. Those who agreed and filled informed consent were
enrolled in the study. A specific code was considered for
each patient, and they were randomly allocated to two study
groups, propacetamol (P) and lidocaine (L).
In the operating room setting, a peripheral I.V. line was
drawn from the patient’s hand, and a ringer lactate (2 cc/kg)
was administered. A standard monitoring system, including
electrocardiogram and noninvasive blood pressure and pulse
oximetry, was set for each participant. One hour preceding
anaesthesia induction, patients in group P received propac-
etamol 2 g/IV/infusion diluted in 100 cc of normal saline
(N.S). Patients in group L received lidocaine (1.5mg/kg)
two minutes before anesthesia. The grouping was concealed
from anesthesiologist performed intubation and also from
patients who participated in the study. Only the researcher
who recorded hemodynamic variables at studied time points
was aware of the grouping that was different from the person
who analyzed the data.
The routine protocol for anaesthesia induction was sim-
ilarly applied for both groups using I.V. administration of
midazolam 0.02mg/kg, fentanyl 2 𝜇g/kg, sodium thiopental
5mg/kg, and atracurium 0.5mg/kg. Three minutes after-
wards, laryngoscopy and tracheal intubation were performed
by two anesthesiologists, using tracheal tubes number 7–
7.5 for men and number 6.5–7 for women. Anesthesia was
maintained based on the operation by means of isoflurane
with or without N
2
O and fentanyl 50 𝜇g each 30 minutes.
Hemodynamic status, including systolic and diastolic
blood pressures (SBP, DBP), mean arterial pressure (MAP),
and heart rate were recorded in a prepared check list for each
individual in six time points, before drug administration (as
baseline), after drug administration (before laryngoscopy),
and at 1, 3, 6, and 9 minutes after tracheal intubation.
2.3. Primary and Secondary Outcomes. Theprimary outcome
was to determine the effects of groups (L versus P) and time
(before intubation and at 1, 3, 6, and 9 minutes after intuba-
tion) onMAP andHR. Secondary outcomes were assessment
of changes in SBP, DBP, MAP, and HR before and after drug
administration, and also their changes within the 9 min-
utes after laryngoscopy. The incidence rates of tachycardia
(HR > 120 beat/min) and bradycardia (HR < 60 beat/min),
hypertension (MAP > 120mmHg), and hypotension (MAP <
70mmHg) were assessed and compared between two groups.
2.4. Statistical Analysis. Results were reported as mean ±
standard deviation (SD) for quantitative variables and per-
centages for categorical variables. SBP, DBP, MAP, and HR
were compared using the unpaired 𝑡-test between two studied
groups. The changes of these variables after drug adminis-
tration were compared assessed using a paired test. A two-
way analysis of variance (ANOVA) with repeated measures
was conducted to determine the effects of groups (L versus
P) and time (before intubation and at 1, 3, 6, and 9 minutes
after intubation) on MAP and HR. In addition, a repeated
measures one-way ANOVA was performed in each group to
determine the effects of time on MAP and HR. Statistical
analysis was performed using SPSS version 21 (SPSS Inc,
Chicago, IL, USA) and statistical significance was accepted
at 𝑃 ≤ 0.05.
3. Results
Of 89 initial patients, 66 patients (Male 32) with themean age
of 41 ± 12 years (range: 20–60 years), who met inclusion cri-
teria, were selected for study procedure and equally divided
into two groups L and P. In total, four patients were removed
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Figure 1: Study diagram.
from the study due to hard intubation (3 patients in group L
and 1 patient in placebo group). Figure 1 shows study fellow
diagram.
Patients’ demographic data in each group is shown in
Table 1. Two groups did not have significant difference for
age, sex, weight, height, ASA class, and endoscopic view (𝑃 ≥
0.2). Hemodynamic status including SBP, DBP,MAP, andHR
before and after drug administration (before laryngoscopy)
has been summarized in Table 2. SBP, DBP, MAP, and HR
were similar between two groups before drug administration
(𝑃 ≥ 0.2). In both groups SBP, DBP, andMAP decreased after
drug administration (𝑃 < 0.001). In group P HR decreased
after drug administration (𝑃 < 0.001), while in group L it did
not change significantly (𝑃 = 0.2).
The trend of SBP, DBP, MAP, and HR changes in each
group has been shown in Figure 2. There was a significant
effect of time onMAP (𝑃 < 0.001), but there was not a signifi-
cant difference between two groups over the time points after
intubation (𝑃 = 0.8). In both groups P and L, MAP increased
after laryngoscopy and the changes were statistically signifi-
cant (𝑃 < 0.001). There were significant effects of groups (P
versus L) and time on HR after intubation (𝑃 ≤ 0.02). There
were significant changes of HR in both groups after intu-
bation, but the trend of changes was not the same between
two groups. In group L, HR increased after intubation and
Table 1: Patients’ baseline data in each group.
Variables Propacetamol(𝑛 = 32)
Lidocaine
(𝑛 = 30) P value
Age (year) 43 ± 12 39 ± 11 0.2
ASA (I/II) 1/31 2/28 0.6
Sex (M/F) 15/17 13/17 0.8
Weight (kg) 74 ± 10 77 ± 10 0.3
Height (cm) 164 ± 15 166 ± 12 0.6
Endoscopic view (I/II) 20/12 19/11 0.9
its change was statistically significant within 9 minutes after
intubation (𝑃 < 0.001). In group P, HR remained stable
within the 9 minutes after intubation (𝑃 = 0.8).
The incidence rates of hypertension (3.0% versus 20.0%,
𝑃 = 0.034), hypotension (0.0% versus 20%, 𝑃 = 0.007), and
tachycardia (3.0% versus 20.0%,𝑃 = 0.034) were significantly
lower in group P as compared to group L (𝑃 < 0.05).
4. Discussion
In the present study, our findings showed beneficial effects of
preoperative administration of propacetamol on attenuation
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Table 2: Hemodynamic variables including systolic, diastolic, andmean arterial blood pressures (SBP, DBP,MAP) and heart rate (HR) before
and after drug in each group.
Variables Propacetamol (𝑁 = 32) Lidocaine (𝑁 = 30)
Before After P value Before After P value
Systolic blood pressure (mmHg) 125 ± 11 112 ± 22 <0.001 126 ± 21 97 ± 21 <0.001
Diastolic blood pressure (mmHg) 82 ± 10 72 ± 9 <0.001 83 ± 14 65 ± 14 <0.001
Mean arterial blood pressure (mmHg) 96 ± 9 86 ± 11 <0.001 97 ± 15 75 ± 17 <0.001
Hear rate (beat/min) 81 ± 8 72 ± 5 <0.001 85 ± 17 89 ± 21 0.2
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Figure 2: Hemodynamic status including systolic, diastolic, and mean arterial blood pressures (SBP, DBP, MAP) and heart rate (HR) within
9 minutes after tracheal intubation in each studied group.
of heart rate responses after tracheal intubation compared to
lidocaine. None of the lidocaine or propacetamol was effec-
tive to attenuate blood pressure responses after laryngoscopy
and changes of MAP after laryngoscopy were significant in
both groups.
Although favorable effects of propacetamol on post-
operative pain management have been well documented
[3–8], there is no published evidence about its preventive
effects on hemodynamic stimulations after tracheal intuba-
tion. However, there are some reports about the effects of
acetaminophen on hemodynamic changes in subjects with
a regular consumption of acetaminophen. These alterations
include increase in blood pressure and cardiovascular events
in subjects consuming acetaminophen [25–28]. In one two-
week randomized crossover trial, acetaminophen (1 g three
times daily) and not placebo increased systolic and diastolic
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blood pressure as determined by ambulatory monitoring
[28]. However, other authors had reverse opinions [29, 30].
It seems that a single injection of propacetamol could not
develop these side effects; however, it was not to attenuate the
responses after laryngoscopy as well.
The exact underlying mechanism of the effect of propac-
etamol on cardiovascular responses is not clear. It might be
attributed to its analgesic action mediated by the antipros-
taglandin effect. Similar to NSAID and aspirin, propacetamol
inhibits cyclooxygenase, prostaglandin H2 synthase in its
analgesic pathway [31]. Propacetamol, however, blocks this
enzyme at its peroxidase catalytic and not cyclooxygenase
catalytic site and is not considered aNSAID. Riad andMoussa
assessed the effects of lornoxicam on hemodynamic changes
after tracheal intubation and found that administration of
8mg of lornoxicam 30 minutes before surgery significantly
decreased HR and BP subsequent laryngoscopy and tracheal
intubation compared to placebo [32]. Lornoxicam, which is a
novel nonsteroidal anti-inflammatory drug (NSAID), ismore
known for its postoperative pain reduction [33].
Lidocaine is used as a routine drug to relieve pain and
cardiovascular responses to tracheal intubation in a consider-
able number of operating rooms. Recent studies have demon-
strated that lidocaine alone or in combination with esmolol
is not as effective as opioids on attenuating blood pressure
and heart rate after intubation [14, 18]. Min et al., in a
well-designed trial on 66 patients who underwent elective
surgery, compared preventive effects of remifentanil 1mg/kg
and lidocaine 1.5mg/kg + esmolol 1mg/kg on hypertension
and tachycardia after endotracheal intubation [14]. They
revealed that remifentanil 1mg/kg is more effective than
the combination of lidocaine 1.5mg/kg and esmolol 1mg/kg
for attenuating hemodynamic responses to rapid sequence
intubation. Incidence rates of hypertension (3% versus 20%),
hypotension (0.0% versus 20%), and tachycardia (3% versus
20%) were significantly lower in group P compared to
group L. Feng et al. reported postintubation tachycardia
(HR > 100 beat/min) and hypertension (SBP > 180mmHg)
in seventy-five percent of patients who received lidocaine
[34]. In our trial, the definitions of tachycardia (HR > 120)
and hypertension (MAP > 120mmHg) were different, which
might explain the observed differences. Further studies are
required to assess various doses of propacetamol in order to
compare it with other drugs like fentanyl, remifentanil, and
esmolol or in combination with other drugs. The selected
patients in our trial were between 20 and 60 years old and
did not have any considerable predisposing factor, which
may have affected their cardiovascular system. If potential
benefits of propacetamol are confirmed, it will be possible
to examine it in more specific cases, including patients with
hypertension, cardiovascular diseases, the elderly, pregnant
patients, and those with contraindication to other drugs.
5. Conclusion
Propacetamol 2 gr one hour prior intubation attenuates heart
rate responses after laryngoscopy, but is not effective to
prevent acute alterations in blood pressure after intubation.
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